- Home
- GANX vs USIO Comparison
GANX vs USIO Comparison
Compare GANX & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GANX | USIO |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.8M | 58.8M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | GANX | USIO |
|---|---|---|
| Price | $1.84 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $7.50 | $4.00 |
| AVG Volume (30 Days) | ★ 329.1K | 322.9K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $55,180.00 | ★ $28,200,535.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $8.57 |
| P/E Ratio | ★ N/A | $234.00 |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $1.53 | $1.03 |
| 52 Week High | $4.34 | $3.06 |
Technical Indicators
Market Signals| Indicator | GANX | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 43.69 |
| Support Level | $1.71 | $2.11 |
| Resistance Level | $1.85 | $2.61 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 90.63 | 17.77 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.